This is happening with CCSVI research and treatment right now too. The FDA got involved (prompted by big pharma perhaps???) and sent out a “warning” of the dangers and how some of the studies, such as the Hubbard IRB, had to be shut down. So sad. The backlash is that now insurance companies won’t pay for the procedure for anyone with an MS DX, and possibly others as this goes on. Oh, they’ll pay to do the same procedure on arteries, but veins are no mans land. ARGH!
I have a good friend who was scheduled to have his 2nd CCSVI procedure (over a year since his first… more of a tune up) last week, who has MS and this FDA thing happened and his insurance suddenly wouldn’t pay for it, so it was cancelled. So frustrating!
All that to say naysayers are going to continue to make waves and we have to just keep plugging away at the research and PROVE them wrong. 😉